BBlogFlow

Canada closely following reports of plague in Russia, health minister says - CityNews Montreal

·Oct 5, 2026
Source: CityNews Montreal
Read the original article

This story deserves to be shared

Send it to someone who'd care, or post it on your networks.

Facebook Twitter Email

OTTAWA — Canada is very closely following reports that a woman who worked at a plague research institute in Siberia has died, Health Minister Marjorie Michel said on Monday.

Russian authorities say the woman contracted pneumonia from an unknown source. They also say there’s no evidence it was caused by any of the pathogens she worked with at the Irkutsk Anti-Plague Research Institute of Siberia and the Far East.

This article is an excerpt. To read the full content, visit the original source. CityNews Montreal

Reactions

0 comments

No comments yet. Be the first to share your thoughts!

Facebook Twitter

Related articles

Canada closely following reports of plague in Russia, health minister says - Toronto Star

This undated photo released in 2019 by the Irkutsk Anti-Plague Research Institute of Siberia and Far East, shows the institute workers in a lab. OTTAWA - Canada is very closely following reports that a woman who worked at a plague research institute in Siberia has died, Health Minister Marjorie Michel said on Monday. Russian authorities say the woman contracted pneumonia from an unknown source. They also say there’s no evidence it was caused by any of the pathogens she worked with at the Irkutsk Anti-Plague Research Institute of Siberia and the Far East.

Toronto Star·

Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Medical Xpress·

Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily

“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.

Oncodaily·